NCT06769126
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06769126
Title Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SWOG Cancer Research Network
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.